- MJ Gleeson director sells
- Judges Scientific director sells 25,791 shares
- Balfour Beatty CFO sells after strong annual share gains
Christopher Mills, non-executive director of affordable house builder MJ Gleeson (GLE) has sold 300,000 shares at 610p for a total value of £1.83 million on 4 October.
The sale was made by the North Atlantic Smaller Companies Investment Trust (NAS) where Mills is the largest shareholder.
Following the sale, Mills is beneficially interested in 6,055,000 ordinary shares of 0.02p each or 10.37% of the company’s issued shares.
In September the affordable house builder said it aims to build 3,000 new homes a year and ‘triple’ profits.
Over the past year MJ Gleeson shares have gained 61% to 622p.
JUDGES SCIENTIFIC DIRECTOR SELLS £2.4 MILLION SHARES
Ralph Elman, non-executive director at science equipment manufacturer Judges Scientific (JDG:AIM) has sold 25,791 shares at £94 for a total value of £2,424,354 million on 1 October.
Following this sale, Elman’s beneficial holding is 37,225 ordinary shares representing approximately 0.56% of the total issued share capital and voting rights in the company.
At the end of September, the world-class scientific instrument maker confirmed its full year outlook. Over the past year the shares have gained 27%.
BALFOUR BEATTY CFO SELLS 240,000 SHARES
Philip Harrison, CFO of Balfour Beatty (BBY) has sold 240,000 shares at 432p for a total value of £1,036,800 on 1 October.
Following the sale of 240,000 shares, Harrison holds a total of 429,252 shares (including shares held by people closely associated with Harrison and excluding unvested awards made under the company’s shares plans).
The company’s first-half results failed to excite investors in mid-August, despite a 9% rise in the half-year dividend to 3.8p per share.
Shares in Balfour Beatty have gained 35% over the past year, although these gains have slowed due to investor scepticism about the future of infrastructure spending under the new Labour government.
